Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [896]

New metronomic approach to neuroblastoma

Prof Frank Berthold - University Hospital Köln, Köln, Germany

New metronomic approach to neuroblastoma ( Prof Frank Berthold - University Hospital Köln, Köln, Germany )

WIN consortium as a basis for forming cross-border collaborations for improving...

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )

Retinoic acid in acute promyelocytic leukaemia as alternative to chemotherapy

Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy

Retinoic acid in acute promyelocytic leukaemia as alternative to chemotherapy ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )

Advances in chronic lymphocytic leukaemia: Expert panel discussion

Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan

Advances in chronic lymphocytic leukaemia: Expert panel discussion ( Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan )

LHRH analogue goserelin helps preserve fertility among women undergoing chemo...

Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA

LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer ( Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA )

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy

Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )

Advances in diagnostic devices in melanoma screening

Dr Alessandro Testori - European Institute of Oncology, Milan, Italy

Advances in diagnostic devices in melanoma screening ( Dr Alessandro Testori - European Institute of Oncology, Milan, Italy )

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second...

Prof Marc Peeters - University of Antwerp, Antwerp, Belgium

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC ( Prof Marc Peeters - University of Antwerp, Antwerp, Belgium )

Success for ipilimumab and nivolumab combo in advanced melanoma

Prof Mario Sznol - Yale Cancer Center, New Haven, USA

Success for ipilimumab and nivolumab combo in advanced melanoma ( Prof Mario Sznol - Yale Cancer Center, New Haven, USA )

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid...

Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )

Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute...

Prof Max Topp - Würzburg University Hospital, Würzburg, Germany

$Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia ( Prof Max Topp - Würzburg University Hospital, Würzburg, Germany )$

Regorafenib shows early promise in colorectal candidates unable to undergo chemo

Dr Enrique Grande - Hospital Ramon y Cajal, Madrid, Spain

Regorafenib shows early promise in colorectal candidates unable to undergo chemo ( Dr Enrique Grande - Hospital Ramon y Cajal, Madrid, Spain )

More from ecancer